• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

SEARCH

SEARCH BY CITATION

References

  • 1
    Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995; 80: 36893698.
  • 2
    Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 1997; 337: 9195.
  • 3
    Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med. 1998; 339: 599603.
  • 4
    Herrmann BL, Saller B, Janssen OE, et al. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab. 2002; 87: 54765484.
  • 5
    Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331: 10561061.
  • 6
    Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet. 2001; 357: 17431748.
  • 7
    Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab. 2005; 90: 63966402.
  • 8
    Hero M, Wickman S, Dunkel L. May Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol (Oxf). 2006; 64: 510513.
  • 9
    Mauras N, Gonzalez de Pijem L, Hsiang HY, et al. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab. 2008; 93: 823831.
  • 10
    Hero M, Makitie O, Kroger H, Nousiainen E, Toiviainen-Salo S, Dunkel L. Impact of Aromatase Inhibitor Therapy on Bone Turnover, Cortical Bone Growth and Vertebral Morphology in Pre- and Peripubertal Boys with Idiopathic Short Stature. Horm Res. 2009; 71: 290297.
  • 11
    Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist 2nd ed vol 1st Stanford University Press, Stanford: 1959.
  • 12
    Bayley NPS. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952; 40: 423441.
  • 13
    Makitie O, Doria AS, Henriques F, et al. Mar Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005; 146: 395401.
  • 14
    Stadnik TW, Lee RR, Coen HL, Neirynck EC, Buisseret TS, Osteaux MJ. Annular tears and disk herniation: prevalence and contrast enhancement on MR images in the absence of low back pain or sciatica. Radiology. 1998; 206: 4955.
  • 15
    Masharawi Y, Rothschild B, Peled N, Hershkovitz I. A simple radiological method for recogninizing osteoporotic thoracic vertebral compression fractures and distinguishing them from Scheuermann disease. Spine. 2009; 34: 19951999.
  • 16
    Caruso-Nicoletti M, Cassorla F, Skerda M, Ross JL, Loriaux DL, Cutler GB Jr. Short term, low dose estradiol accelerates ulnar growth in boys. J Clin Endocrinol Metab. 1985; 61: 896898.
  • 17
    Weise M, De-Levi S, Barnes KM, Gafni RI, Abad V, Baron J. Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci U S A. 2001; 98: 68716876.
  • 18
    Eshet R, Maor G, Ben Ari T, Ben Eliezer M, Gat-Yablonski G, Phillip M. The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice. J Endocrinol. 2004; 182: 165172.
  • 19
    Ascani E, La Rosa G, Ascani C., Scheuermann kyphosis. In: WeinsteinS, (ed) The Pediatric Spine: Principles and Practise 2nd edition ed, Lippincott, Williams & Wilkins, Philadelphia, USA, pp. 2001; 413431.
  • 20
    Mauras N, O'Brien KO, Klein KO, Hayes V. Estrogen suppression in males metabolic effects. J Clin Endocrinol Metab. 2000; 85: 23702377.
  • 21
    Nakhla M, Scuccimarri R, Duffy KN, et al. Prevalence of Vertebral Fractures in Children with Chronic Rheumatic Diseases at Risk for Osteopenia. J Pediatr. 2009; 154: 438443.
  • 22
    Valta H, Lahdenne P, Jalanko H, Aalto K, Makitie O. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007; 34: 831836.
  • 23
    Valta H, Jalanko H, Holmberg C, Helenius I, Makitie O. Impaired bone health in adolescents after liver transplantation. Am J Transplant. 2008; 8: 150157.
  • 24
    Valta H, Makitie O, Ronnholm K, Jalanko H. Bone Health in Children and Adolescents after Renal Transplantation. J Bone Miner Res. 2009; 24: 16991708.
  • 25
    Niemelainen R, Battie MC, Gill K, Videman T. The prevalence and characteristics of thoracic magnetic resonance imaging findings in men. Spine. 2008; 33: 25522559.